A & G SOLUTIONS GLOBAL LIMITED
⚠️ High Risk
FEI: 3021074016 • Lagos • NIGERIA
FEI Number
3021074016
Location
Lagos
Country
NIGERIAAddress
Ajao Estate, 1b Olabode Street, Lagos, , Nigeria
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 6/16/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 62NDH07AMINOLEVULINIC ACID HYDROCHLORIDE (ANTI-PSORIATIC) | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 61PDY62PIOGLITAZONE HCL | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 64LDY56PREDNISONE (GLUCOCORTICOID) | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 61TDY17PROMETHAZINE HCL (ANTI-EMETIC/NAUSEANT) | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 62GDB90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY) | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 56BDY03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | Division of Southeast Imports (DSEI) | |
| 6/16/2025 | 56CDY70CEFTRIAXONE SODIUM (CEPHALOSPORINS) | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is A & G SOLUTIONS GLOBAL LIMITED's FDA import refusal history?
A & G SOLUTIONS GLOBAL LIMITED (FEI: 3021074016) has 12 FDA import refusal record(s) in our database, spanning from 6/16/2025 to 6/16/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. A & G SOLUTIONS GLOBAL LIMITED's FEI number is 3021074016.
What types of violations has A & G SOLUTIONS GLOBAL LIMITED received?
A & G SOLUTIONS GLOBAL LIMITED has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about A & G SOLUTIONS GLOBAL LIMITED come from?
All FDA import refusal data for A & G SOLUTIONS GLOBAL LIMITED is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.